Extracellular vesicles (EVs) are small vesicles deriving from all cell types during cell activation, involved in transcellular communication, and regarded as predictors of vascular damage and of cardiovascular events. The investigators will test the hypothesis that, in patients on chronic low-dose aspirin treatment for cardiovascular prevention, aspirin may affect the release of EVs within the 24 hours interval.
Study Type
OBSERVATIONAL
Enrollment
93
Kinetics of circulating extracellular vesicles after low-dose aspirin administration
In patients receiving low-dose aspirin for cardiovascular prevention, evaluate the potential effects of chronic aspirin treatment on circulating extracellular vesicles levels over the 24-hour interval
Time frame: 1st - 12th month
Aspirin response and circulating extracellular vesicles over the 24-hour
In patients receiving low-dose aspirin for cardiovascular prevention, evaluate the role of circulating extracellular vesicles as a potential determinant of interindividual variability in the aspirin response
Time frame: 13th - 24th month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.